Commit Biologics ("Commit"), today announced positive results from a non-human primate (NHP) study demonstrating proof-of-concept for its proprietary Complement Engager (BiCE™) platform. The study ...

Single subcutaneous dose of ADX-038 achieved near-complete alternative pathway suppression for 6 months, supporting potent and selective CFB ...

A longevity expert reveals how immune systems begin aging after 35, making people more susceptible to infections and immune-related disorders over time.

Dr Manav Manchanda explains whether air purifiers can really prevent pneumonia and how they help support lung health during ...

Blocking the mechanism that cancer cells exploit to avoid destruction by the immune system could spur new treatments for the ...

A biomedical researcher combining advanced mouse models with human-based and computational approaches explains why we can’t ...

Apellis Pharmaceuticals (NASDAQ: APLS) is preparing to release its quarterly earnings on Thursday, 2025-10-30. Here's a brief overview of what investors should keep in mind before the announcement.

Livestock producers looking for a less expensive winter supplement this year should consider alfalfa for its nutritional ...

Glioblastoma is an aggressive brain cancer that almost always recurs after surgery and radiochemotherapy. Now, researchers ...

Discusses Immunology Portfolio Update and Advances in Autoimmune Therapies October 30, 2025 11:30 AM EDTCompany ...

Still, human data is more nuanced. “While the evidence that the gut microbiome affects mood is relatively strong, evidence ...